While tau was known to be involved in AD pathology, its role in primary tauopathies and “frontotemporal lobar degeneration-tau” (FTLD-tau) cases was not known until monogenic missense and splice-site mutations were discovered in the MAPT gene [42, 64, 72]. The gene discussed is MAPT; the disease is Alzheimer disease.